Compare NEXT & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEXT | PBH |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 2014 | 2004 |
| Metric | NEXT | PBH |
|---|---|---|
| Price | $6.32 | $45.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $8.70 | ★ $67.80 |
| AVG Volume (30 Days) | ★ 2.1M | 451.4K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | N/A | $17.03 |
| Revenue Next Year | N/A | $6.06 |
| P/E Ratio | ★ N/A | $76.54 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $4.75 | $42.62 |
| 52 Week High | $9.24 | $71.07 |
| Indicator | NEXT | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 39.28 |
| Support Level | $6.04 | $44.73 |
| Resistance Level | $6.47 | $49.79 |
| Average True Range (ATR) | 0.28 | 1.30 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 3.27 | 32.07 |
NextDecade Corp is a Houston-based energy company engaged in construction and development activities related to the liquefaction of natural gas, the sale of LNG, and the capture and storage of CO2 emissions. The group is constructing and developing a natural gas liquefaction and export facility located in the Rio Grande Valley near Brownsville, Texas (the Rio Grande LNG Facility). It also engaged in NEXT Carbon Solutions, advancing proprietary processes to lower the cost of utilizing carbon capture and storage (CCS) and help companies reduce their emissions and achieve their clean energy goals.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.